Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$0.36 - $0.74 $10,882 - $22,369
-30,229 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$0.6 - $1.7 $9,118 - $25,836
15,198 Added 101.11%
30,229 $21,000
Q4 2021

Feb 17, 2022

BUY
$1.63 - $4.28 $24,500 - $64,332
15,031 New
15,031 $25,000
Q1 2021

May 19, 2021

SELL
$7.94 - $14.87 $129,263 - $242,083
-16,280 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$5.92 - $33.96 $96,377 - $552,868
16,280 New
16,280 $242,000

About Scopus BioPharma Inc.


  • Ticker SCPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,094,300
  • Description
  • Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...
More about SCPS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.